JP Morgan Chase’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.72B | Sell |
4,231,033
-362,861
| -8% | -$159M | 0.1% | 194 |
|
|
2026
Q1 | $2.08B | Buy |
4,593,894
+513,014
| +13% | +$260M | 0.13% | 155 |
|
|
2025
Q4 | $2.31B | Buy |
4,080,880
+580,606
| +17% | +$309M | 0.15% | 150 |
|
|
2025
Q3 | $1.57B | Sell |
3,500,274
-4,175,405
| -54% | -$2B | 0.09% | 204 |
|
|
2025
Q2 | $4.17B | Sell |
7,675,679
-896,971
| -10% | -$469M | 0.27% | 79 |
|
|
2025
Q1 | $4.25B | Sell |
8,572,650
-1,576,385
| -16% | -$872M | 0.31% | 70 |
|
|
2024
Q4 | $5.3B | Buy |
10,149,035
+150,417
| +2% | +$78.3M | 0.39% | 39 |
|
|
2024
Q3 | $4.91B | Buy |
9,998,618
+1,076,519
| +12% | +$501M | 0.37% | 47 |
|
|
2024
Q2 | $3.97B | Buy |
8,922,099
+2,189,792
| +33% | +$872M | 0.33% | 58 |
|
|
2024
Q1 | $2.69B | Buy |
6,732,307
+1,521,709
| +29% | +$575M | 0.23% | 95 |
|
|
2023
Q4 | $1.76B | Sell |
5,210,598
-1,802,349
| -26% | -$537M | 0.17% | 129 |
|
|
2023
Q3 | $2.05B | Sell |
7,012,947
-1,005,729
| -13% | -$314M | 0.23% | 101 |
|
|
2023
Q2 | $2.74B | Buy |
8,018,676
+826,885
| +11% | +$250M | 0.3% | 81 |
|
|
2023
Q1 | $1.84B | Sell |
7,191,791
-1,437,571
| -17% | -$354M | 0.22% | 105 |
|
|
2022
Q4 | $2.29B | Buy |
8,629,362
+298,510
| +4% | +$72.8M | 0.3% | 84 |
|
|
2022
Q3 | $1.56B | Buy |
8,330,852
+72,982
| +0.9% | +$15.7M | 0.22% | 106 |
|
|
2022
Q2 | $1.66B | Buy |
8,257,870
+856,354
| +12% | +$201M | 0.23% | 100 |
|
|
2022
Q1 | $2.23B | Buy |
7,401,516
+1,422,984
| +24% | +$416M | 0.27% | 84 |
|
|
2021
Q4 | $2.15B | Buy |
5,978,532
+353,895
| +6% | +$122M | 0.25% | 85 |
|
|
2021
Q3 | $1.86B | Sell |
5,624,637
-345,879
| -6% | -$116M | 0.23% | 97 |
|
|
2021
Q2 | $1.83B | Buy |
5,970,516
+137,283
| +2% | +$38.5M | 0.22% | 103 |
|
|
2021
Q1 | $1.44B | Buy |
5,833,233
+647,181
| +12% | +$163M | 0.19% | 124 |
|
|
2020
Q4 | $1.41B | Buy |
5,186,052
+137,529
| +3% | +$34.1M | 0.21% | 115 |
|
|
2020
Q3 | $1.17B | Sell |
5,048,523
-156,663
| -3% | -$35.2M | 0.2% | 112 |
|
|
2020
Q2 | $989M | Sell |
5,205,186
-77,529
| -1% | -$13.9M | 0.19% | 123 |
|
|
2020
Q1 | $872M | Sell |
5,282,715
-586,860
| -10% | -$107M | 0.2% | 105 |
|
|
2019
Q4 | $1.16B | Sell |
5,869,575
-105,654
| -2% | -$19.8M | 0.22% | 102 |
|
|
2019
Q3 | $1.08B | Sell |
5,975,229
-1,366,929
| -19% | -$236M | 0.21% | 103 |
|
|
2019
Q2 | $1.27B | Buy |
7,342,158
+394,248
| +6% | +$67.6M | 0.25% | 82 |
|
|
2019
Q1 | $1.32B | Buy |
6,947,910
+609,252
| +10% | +$108M | 0.27% | 83 |
|
|
2018
Q4 | $1.01B | Sell |
6,338,658
-97,149
| -2% | -$16.5M | 0.23% | 95 |
|
|
2018
Q3 | $1.23B | Sell |
6,435,807
-713,205
| -10% | -$127M | 0.24% | 89 |
|
|
2018
Q2 | $1.14B | Sell |
7,149,012
-19,806
| -0.3% | -$3.02M | 0.23% | 89 |
|
|
2018
Q1 | $987M | Buy |
7,168,818
+308,703
| +4% | +$43.1M | 0.21% | 105 |
|
|
2017
Q4 | $835M | Sell |
6,860,115
-595,701
| -8% | -$74.6M | 0.18% | 125 |
|
|
2017
Q3 | $850M | Sell |
7,455,816
-181,188
| -2% | -$19.7M | 0.19% | 111 |
|
|
2017
Q2 | $794M | Buy |
7,637,004
+339,525
| +5% | +$32.6M | 0.18% | 119 |
|
|
2017
Q1 | $621M | Sell |
7,297,479
-390,708
| -5% | -$30.9M | 0.14% | 161 |
|
|
2016
Q4 | $543M | Buy |
7,688,187
+1,233,261
| +19% | +$90.7M | 0.13% | 175 |
|
|
2016
Q3 | $521M | Buy |
6,454,926
+882,486
| +16% | +$67.6M | 0.13% | 186 |
|
|
2016
Q2 | $410M | Buy |
5,572,440
+2,603,970
| +88% | +$183M | 0.1% | 225 |
|
|
2016
Q1 | $198M | Buy |
2,968,470
+2,569,410
| +644% | +$159M | 0.05% | 370 |
|
|
2015
Q4 | $24.2M | Buy |
399,060
+101,817
| +34% | +$5.72M | 0.01% | 1204 |
|
|
2015
Q3 | $15.2M | Sell |
297,243
-479,223
| -62% | -$27.1M | ﹤0.01% | 1453 |
|
|
2015
Q2 | $41.8M | Sell |
776,466
-92,097
| -11% | -$5.15M | 0.01% | 981 |
|
|
2015
Q1 | $48.7M | Sell |
868,563
-159,237
| -15% | -$9.01M | 0.01% | 909 |
|
|
2014
Q4 | $60.4M | Sell |
1,027,800
-270,450
| -21% | -$15.1M | 0.01% | 851 |
|
|
2014
Q3 | $66.6M | Sell |
1,298,250
-237,762
| -15% | -$11.8M | 0.02% | 782 |
|
|
2014
Q2 | $70.3M | Buy |
1,536,012
+432,720
| +39% | +$19.1M | 0.02% | 692 |
|
|
2014
Q1 | $53.7M | Sell |
1,103,292
-193,212
| -15% | -$9.1M | 0.01% | 774 |
|
|
2013
Q4 | $55.3M | Sell |
1,296,504
-848,556
| -40% | -$35.7M | 0.02% | 754 |
|
|
2013
Q3 | $89.7M | Sell |
2,145,060
-5,005,458
| -70% | -$221M | 0.03% | 576 |
|
|
2013
Q2 | $402M | Buy |
+7,150,518
| New | +$394M | 0.13% | 184 |
|
Other funds holding ISRG
N
JP Morgan Chase's ISRG Position: Q2 2026 in Review
JP Morgan Chase reduced its Intuitive Surgical (ISRG) stake by 7.9% in Q2 2026, selling an estimated $159M and leaving 4,231,033 shares worth $1.72B. The position accounts for 0.1% of the portfolio, ranked #194.
JP Morgan Chase first reported a position in ISRG in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.3B in Q4 2024. 1,676 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- JP Morgan Chase held 4,231,033 shares of Intuitive Surgical worth $1.72B as of Q2 2026.
- JP Morgan Chase sold 362,861 Intuitive Surgical shares in Q2 2026, an estimated $159M.
- Intuitive Surgical made up 0.1% of JP Morgan Chase's portfolio in Q2 2026, its #194 holding.
- JP Morgan Chase first reported a position in Intuitive Surgical in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Intuitive Surgical position peaked at $5.3B in Q4 2024.
- 1,676 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.